FEBRUARY 18, 2012

ASCO 2009 - Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ-Cell Tumors: Updated Analysis of a Randomized Trial with 8 years Follow-up - Session Highlights

E-mail Print

ORLANDO, FL, USA (UroToday.com) - The objective of this study was to further define the safety and efficacy of bevacizumab therapy in patients with metastatic renal cell carcinoma (mRCC), prior to surgery.




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |